Examples of using Combination with cyclophosphamide in English and their translations into Dutch
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
Busilvex in combination with cyclophosphamide.
The recommended dose of Busilvex is 0.8 mg per kg of body weight, in combination with cyclophosphamide.
Busilvex in combination with cyclophosphamide or melphalan.
Busilvex is used in combination with cyclophosphamide or melphalan.
Busilvex in combination with cyclophosphamide or melphalan In adults.
standard doxorubicin in combination with cyclophosphamide responded to treatment.
Corticosteroids in combination with cyclophosphamide are the mainstay of the induction treatment for childhood GPA/MPA.
In adults Busilvex is used in combination with cyclophosphamide.
When used in combination with cyclophosphamide or melphalan the recommended dose of Busulfan Fresenius Kabi in adults is 0.8 mg per kilogram body weight.
doxorubicin, both in combination with cyclophosphamide, in 297 women.
When Busilvex was given in combination with cyclophosphamide or melphalan, all adults
Adverse reactions from pooled study results of three randomised Phase III clinical trials of Myocet as a single agent and in combination with Cyclophosphamide CPA.
The recommended dose of Busilvex in combination with cyclophosphamide or melphalan is based on your body weight varying between 0.8 and 1.2 mg/kg.
versus doxorubicin(60 mg/ m²) in combination with cyclophosphamide(600 mg/ m²) AC arm.
Busilvex in combination with cyclophosphamide or melphalan has been studied in patients,
Therefore, the Committee decided that Myocet' s benefits are greater than its risks, in combination with cyclophosphamide, for the first-line treatment of metastatic breast cancer in women.
In a phase III study in combination with cyclophosphamide(CPA) comparing Myocet(60 mg/ m2)+ CPA(600 mg/ m2) versus doxorubicin(60 mg/ m2)+ CPA(600 mg/ m2),
efficacy of Busilvex in combination with cyclophosphamide in the BuCy2 regimen prior to conventional allogeneic and/
In the third study, 46% of the patients taking Myocet in combination with cyclophosphamide responded to treatment, compared with 39% of those receiving epirubicin in combination with cyclophosphamide.
efficacy of Busilvex in combination with cyclophosphamide in the BuCy2 regimen prior to conventional allogeneic and/or autologous HPCT derives from two clinical trials OMC-BUS-4 and OMC-BUS-3.
standard doxorubicin in combination with cyclophosphamide responded to treatment,
efficacy of Busilvex in combination with cyclophosphamide in the BuCy4 or with melphalan in the BuMel regimen prior to conventional allogeneic and/or autologous HPCT derives from clinical trial F60002 IN 101 G0.
Following adjuvant chemotherapy with doxorubicin and cyclophosphamide, in combination with paclitaxel or docetaxel.